JP2006502748A5 - - Google Patents

Info

Publication number

JP2006502748A5

JP2006502748A5 JP2005501601A JP2005501601A JP2006502748A5 JP 2006502748 A5 JP2006502748 A5 JP 2006502748A5 JP 2005501601 A JP2005501601 A JP 2005501601A JP 2005501601 A JP2005501601 A JP 2005501601A JP 2006502748 A5 JP2006502748 A5 JP 2006502748A5

Authority

JP

Japan

Prior art keywords

gene

vector

cell

gene targeting

gfp

Prior art date

2003-09-05

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000623 proteins and genes Proteins 0.000 claims description 12
• 208000007056 sickle cell anemia Diseases 0.000 claims description 2
• 239000013598 vector Substances 0.000 claims 8
• 210000004027 cell Anatomy 0.000 claims 4
• 201000010099 disease Diseases 0.000 claims 3
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
• 208000015181 infectious disease Diseases 0.000 claims 3
• 206010010099 Combined immunodeficiency Diseases 0.000 claims 1
• 208000035473 Communicable disease Diseases 0.000 claims 1
• 241000702421 Dependoparvovirus Species 0.000 claims 1
• 208000031886 HIV Infections Diseases 0.000 claims 1
• 208000037357 HIV infectious disease Diseases 0.000 claims 1
• 208000031220 Hemophilia Diseases 0.000 claims 1
• 208000009292 Hemophilia A Diseases 0.000 claims 1
• 102000018697 Membrane Proteins Human genes 0.000 claims 1
• 108010052285 Membrane Proteins Proteins 0.000 claims 1
• 210000001744 T-lymphocyte Anatomy 0.000 claims 1
• 239000003814 drug Substances 0.000 claims 1
• 230000002068 genetic effect Effects 0.000 claims 1
• 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 239000002243 precursor Substances 0.000 claims 1
• 230000000069 prophylactic effect Effects 0.000 claims 1
• 230000001225 therapeutic effect Effects 0.000 claims 1
• 239000013603 viral vector Substances 0.000 claims 1
• 238000010363 gene targeting Methods 0.000 description 32
• 101710163270 Nuclease Proteins 0.000 description 19
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 14
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 14
• 239000005090 green fluorescent protein Substances 0.000 description 14
• 101150066002 GFP gene Proteins 0.000 description 12
• 239000013612 plasmid Substances 0.000 description 11
• 241000701022 Cytomegalovirus Species 0.000 description 7
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
• 238000003780 insertion Methods 0.000 description 6
• 230000037431 insertion Effects 0.000 description 6
• 238000001890 transfection Methods 0.000 description 6
• 239000011701 zinc Substances 0.000 description 6
• 229910052725 zinc Inorganic materials 0.000 description 6
• 239000000758 substrate Substances 0.000 description 5
• 108091026890 Coding region Proteins 0.000 description 4
• 150000001413 amino acids Chemical class 0.000 description 4
• 238000012761 co-transfection Methods 0.000 description 3
• 238000002474 experimental method Methods 0.000 description 3
• 239000013613 expression plasmid Substances 0.000 description 3
• 238000000684 flow cytometry Methods 0.000 description 3
• 125000006850 spacer group Chemical group 0.000 description 3
• 108020004705 Codon Proteins 0.000 description 2
• 108020004414 DNA Proteins 0.000 description 2
• 108010042407 Endonucleases Proteins 0.000 description 2
• 102000004533 Endonucleases Human genes 0.000 description 2
• 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 2
• 108010077850 Nuclear Localization Signals Proteins 0.000 description 2
• 108010004729 Phycoerythrin Proteins 0.000 description 2
• 108091081024 Start codon Proteins 0.000 description 2
• 238000010586 diagram Methods 0.000 description 2
• 230000006698 induction Effects 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
• 230000001105 regulatory effect Effects 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• BRZYSWJRSDMWLG-DJWUNRQOSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-DJWUNRQOSA-N 0.000 description 1
• 108010087504 Beta-Globulins Proteins 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 102000018682 Interleukin Receptor Common gamma Subunit Human genes 0.000 description 1
• 108010066719 Interleukin Receptor Common gamma Subunit Proteins 0.000 description 1
• 108010025815 Kanamycin Kinase Proteins 0.000 description 1
• 241000283923 Marmota monax Species 0.000 description 1
• 108020004485 Nonsense Codon Proteins 0.000 description 1
• 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 1
• 108091081021 Sense strand Proteins 0.000 description 1
• 108700005078 Synthetic Genes Proteins 0.000 description 1
• 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• 239000000833 heterodimer Substances 0.000 description 1
• 239000000710 homodimer Substances 0.000 description 1
• 238000002826 magnetic-activated cell sorting Methods 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 239000011325 microbead Substances 0.000 description 1
• 230000037434 nonsense mutation Effects 0.000 description 1
• 108020004707 nucleic acids Proteins 0.000 description 1
• 102000039446 nucleic acids Human genes 0.000 description 1
• 150000007523 nucleic acids Chemical class 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 230000001124 posttranscriptional effect Effects 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 229950010131 puromycin Drugs 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1